Development of Prosocial Behaviors and Related Brain Network in Infants of High and Low Risk of ASD

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to compare the developmental trajectories of prosocial behaviors and functional network connections in infants and toddlers at high and low risk of autism spectrum disorder (ASD). The main questions it aims to answer are what the differences in prosocial behaviors and related brain network connections between infants/toddlers at high and low risk of ASD are. Participants will receive developmental and social communicational assessments (Griffiths Mental Developmental Scales, Peabody Developmental Motor Scales, The Communication and Symbolic Behavior Scales Developmental Profile Infant-Toddler Checklist), resting-state EEG and MRI in a natural sleeping state.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 1
Healthy Volunteers: t
View:

• Subjects were enrolled as high-risk if they had an older sibling with a clinical diagnosis of ASD confirmed on the Autism Diagnostic Observation Schedule, second edition (ADOS-2) or Autism Diagnostic Interview (ADI-R).

• Subjects were enrolled in the low-risk group if they had an older sibling without evidence of ASD and no family history of a first or second-degree relative with ASD.

Locations
Other Locations
China
Children's Hospital of Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Bingrui Zhou, doctor
zbr1800@163.com
13701989113
Backup
Chunchun Hu, master
172113062@qq.com
15800850080
Time Frame
Start Date: 2024-04-01
Estimated Completion Date: 2029-07-01
Participants
Target number of participants: 100
Treatments
high-risk group
Subjects in the case group have one or more older siblings with ASD.
low-risk group
Subjects in the controlled group do not have older siblings with ASD.
Related Therapeutic Areas
Sponsors
Collaborators: ShanghaiTech University
Leads: Children's Hospital of Fudan University

This content was sourced from clinicaltrials.gov